Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Mapping the immune checkpoint receptor-ligand landscape in newly diagnosed multiple myeloma may help prioritize patients for immune checkpoint inhibitor therapy

Steven Foltz, Reyka Jayasinghe, MMRF Immune Atlas Network, David Avigan, Samir Parekh, Ravi Vij, Shaji Kumar, Taxiarchis Kourelis, Sagar Lonial, Hearn Cho, Ioannis Vlachos, Sacha Gnjatic, Li Ding, Manoj Bhasin, Chaitanya Acharya, Alexander Gout, George Mulligan

Blood (2025) 146 (Supplement 1): 4024.

https://doi.org/10.1182/blood-2025-4024

Published: 2025

Journal Articles

Commpass explorer: An interactive platform to explore clinico-genomic data from newly diagnosed multiple myeloma patients from the commpass observational trial

Wanxing Zhang, Chaitanya Acharya, Steven Foltz, MMRF Immune Atlas Network, David Avigan, Samir Parekh, Ravi Vij, Shaji Kumar, Taxiarchis Kourelis, Sagar Lonial, Hearn Cho, Ioannis Vlachos, Sacha Gnjatic, Li Ding, Manoj Bhasin, George Mulligan

Blood (2025) 146 (Supplement 1): 7470.

https://doi.org/10.1182/blood-2025-7470

Published: 2025

Journal Articles

Daratumumab-based quadruplet therapy in functional high-risk relapse/refractory multiple myeloma patients induces changes associated with CD8 T cell signaling, activation and expansion

Chaitanya Acharya, Reyka Jayasinghe, Darwin D'Souza, Mark Hamilton, Steven Foltz, Zhihong Chen, Seunghee Kim-Schulze, Hearn Cho, Shaji Kumar, George Mulligan

Blood (2025) 146 (Supplement 1): 3955.

https://doi.org/10.1182/blood-2025-3955

Published: 2025

Journal Articles

Multimodal Single-Cell Profiling of Minimal Residual Disease in B Acute Lymphoblastic Leukemia Reveals Genetic and Non-Genetic Factors of Early Drug Resistance

Rushabh Mehta, Changya Chen, Fatemeh Alikarami, Steven Foltz, Avi Loren, Elizabeth Li, Jason Xu, Marilyn M. Li, Kathrin M. Bernt, Kai Tan

Blood (2024) 144 (Supplement 1): 316.

https://doi.org/10.1182/blood-2024-210504

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Mapping the immune checkpoint receptor-ligand landscape in newly diagnosed multiple myeloma may help prioritize patients for immune checkpoint inhibitor therapy

Commpass explorer: An interactive platform to explore clinico-genomic data from newly diagnosed multiple myeloma patients from the commpass observational trial

Daratumumab-based quadruplet therapy in functional high-risk relapse/refractory multiple myeloma patients induces changes associated with CD8 T cell signaling, activation and expansion

Multimodal Single-Cell Profiling of Minimal Residual Disease in B Acute Lymphoblastic Leukemia Reveals Genetic and Non-Genetic Factors of Early Drug Resistance

Email alerts

ASH Publications

American Society of Hematology

Update search

Mapping the immune checkpoint receptor-ligand landscape in newly diagnosed multiple myeloma may help prioritize patients for immune checkpoint inhibitor therapy

Commpass explorer: An interactive platform to explore clinico-genomic data from newly diagnosed multiple myeloma patients from the commpass observational trial

Daratumumab-based quadruplet therapy in functional high-risk relapse/refractory multiple myeloma patients induces changes associated with CD8 T cell signaling, activation and expansion

Multimodal Single-Cell Profiling of Minimal Residual Disease in B Acute Lymphoblastic Leukemia Reveals Genetic and Non-Genetic Factors of Early Drug Resistance

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only